4.755
price down icon7.67%   -0.395
after-market Dopo l'orario di chiusura: 4.84 0.085 +1.79%
loading
Precedente Chiudi:
$5.15
Aprire:
$5
Volume 24 ore:
3.48M
Relative Volume:
2.67
Capitalizzazione di mercato:
$432.99M
Reddito:
$58.36M
Utile/perdita netta:
$-25.72M
Rapporto P/E:
-10.57
EPS:
-0.45
Flusso di cassa netto:
$-24.91M
1 W Prestazione:
-15.99%
1M Prestazione:
-3.94%
6M Prestazione:
+35.09%
1 anno Prestazione:
+197.19%
Intervallo 1D:
Value
$4.62
$5.12
Intervallo di 1 settimana:
Value
$4.62
$5.80
Portata 52W:
Value
$1.52
$6.23

Aquestive Therapeutics Inc Stock (AQST) Company Profile

Name
Nome
Aquestive Therapeutics Inc
Name
Telefono
908-941-1900
Name
Indirizzo
30 TECHNOLOGY DRIVE, WARREN, NJ
Name
Dipendente
135
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-18
Name
Ultimi documenti SEC
Name
AQST's Discussions on Twitter

Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-04-07 Ripresa RBC Capital Mkts Outperform
2019-04-22 Iniziato H.C. Wainwright Buy
2019-01-03 Iniziato Lake Street Buy
2018-08-20 Iniziato JMP Securities Mkt Outperform
2018-08-20 Iniziato RBC Capital Mkts Outperform

Aquestive Therapeutics Inc Borsa (AQST) Ultime notizie

pulisher
02:09 AM

Aquestive: Rare Opportunity With Dual Platform Strategy (NASDAQ:AQST) - Seeking Alpha

02:09 AM
pulisher
10:37 AM

Aquestive Therapeutics (NASDAQ:AQST) Announces Quarterly Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat

10:37 AM
pulisher
05:06 AM

Aquestive Therapeutics: Q3 Earnings Snapshot - mySA

05:06 AM
pulisher
Nov 04, 2024

Aquestive Therapeutics (AQST) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

Aquestive Therapeutics reports Q3 EPS (13c), consensus (13c) - TipRanks

Nov 04, 2024
pulisher
Nov 04, 2024

AQSTAquestive Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 04, 2024
pulisher
Nov 04, 2024

Aquestive Therapeutics (AQST) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

Aquestive Therapeutics Optimistic Financial and Strategic Outlook - TipRanks

Nov 04, 2024
pulisher
Nov 04, 2024

Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

Aquestive Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 04, 2024
pulisher
Nov 01, 2024

Aquestive Therapeutics Inc (AQST) Q3 2024: Everything You Need T - GuruFocus.com

Nov 01, 2024
pulisher
Nov 01, 2024

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives $8.83 Consensus Target Price from Brokerages - MarketBeat

Nov 01, 2024
pulisher
Oct 29, 2024

Learn to Evaluate (AQST) using the Charts - Stock Traders Daily

Oct 29, 2024
pulisher
Oct 28, 2024

Aquestive Therapeutics (NASDAQ:AQST) Price Target Raised to $13.00 - Defense World

Oct 28, 2024
pulisher
Oct 28, 2024

Aquestive Therapeutics (AQST) Set to Announce Quarterly Earnings on Monday - MarketBeat

Oct 28, 2024
pulisher
Oct 26, 2024

Leerink raises Aquestive Therapeutics stock PT on 'top-line' study results - Investing.com Canada

Oct 26, 2024
pulisher
Oct 25, 2024

Aquestive Therapeutics to Present Subsequent Analysis of - GlobeNewswire

Oct 25, 2024
pulisher
Oct 25, 2024

Leerink Partners Raises Aquestive Therapeutics (NASDAQ:AQST) Price Target to $13.00 - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

Aquestive Therapeutics (NASDAQ:AQST) Stock Rating Reaffirmed by HC Wainwright - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

Aquestive Therapeutics’ Breakthrough in Allergy Treatment Study - Yahoo Finance

Oct 25, 2024
pulisher
Oct 25, 2024

Aquestive Therapeutics to Present Subsequent Analysis of Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Demonstrating Comparable PK and PD Data to Epinephrine Injection Regardless of Variable Placement or Intraoral Movement at American - GlobeNewswire

Oct 25, 2024
pulisher
Oct 25, 2024

Institutions profited after Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) market cap rose US$51m last week but individual investors profited the most - Simply Wall St

Oct 25, 2024
pulisher
Oct 24, 2024

Aquestive Therapeutics' SWOT analysis: stock poised for growth as Anaphylm nears FDA submission - Investing.com Australia

Oct 24, 2024
pulisher
Oct 24, 2024

Aquestive Therapeutics Pushes Retail Sentiment Into ‘Extremely Bullish’ Zone On OAS Drug Trial Success - Barchart

Oct 24, 2024
pulisher
Oct 24, 2024

Aquestive Therapeutics' SWOT analysis: stock poised for growth as Anaphylm nears FDA submission By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 24, 2024

Aquestive Therapeutics Inc (AQST) Has Recovered 74.67% From Its Low: Is This The Beginning Of A Trend? - Stocks Register

Oct 24, 2024
pulisher
Oct 24, 2024

Aquestive Therapeutics Announces Positive Topline Results - GlobeNewswire

Oct 24, 2024
pulisher
Oct 22, 2024

Aquestive Therapeutics a new overweight at Piper on oral film products - MSN

Oct 22, 2024
pulisher
Oct 21, 2024

Aquestive Therapeutics to Report Third Quarter 2024 - GlobeNewswire

Oct 21, 2024
pulisher
Oct 16, 2024

Aquestive Therapeutics updates bylaws, shortens nomination look-back By Investing.com - Investing.com South Africa

Oct 16, 2024
pulisher
Oct 16, 2024

Aquestive Therapeutics updates bylaws, shortens nomination look-back - Investing.com India

Oct 16, 2024
pulisher
Oct 15, 2024

Investing in Aquestive Therapeutics Inc (AQST) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - US Post News

Oct 15, 2024
pulisher
Oct 14, 2024

Financial Snapshot: Analyzing Aquestive Therapeutics Inc (AQST)’s Key Ratio Metrics - The Dwinnex

Oct 14, 2024
pulisher
Oct 09, 2024

Top investors say Aquestive Therapeutics Inc (AQST) ticks everything they need - SETE News

Oct 09, 2024
pulisher
Oct 08, 2024

Aquestive Therapeutics (NASDAQ:AQST) Given "Market Outperform" Rating at JMP Securities - MarketBeat

Oct 08, 2024
pulisher
Oct 08, 2024

In the Green: Aquestive Therapeutics Inc (AQST) Closes at 4.85, Up/Down -2.02 from Previous Day - The Dwinnex

Oct 08, 2024
pulisher
Oct 08, 2024

Should investors be concerned about Aquestive Therapeutics Inc (AQST)? - US Post News

Oct 08, 2024
pulisher
Oct 07, 2024

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives $8.67 Average Price Target from Brokerages - MarketBeat

Oct 07, 2024
pulisher
Oct 06, 2024

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Position Trimmed by Renaissance Technologies LLC - MarketBeat

Oct 06, 2024
pulisher
Oct 02, 2024

A better buy-in window may exist right now for Aquestive Therapeutics Inc (AQST) - SETE News

Oct 02, 2024
pulisher
Oct 01, 2024

Can you now get a good deal on Aquestive Therapeutics Inc’s shares? - US Post News

Oct 01, 2024
pulisher
Sep 30, 2024

Aquestive Therapeutics stock target lifted, rating held on product pipeline By Investing.com - Investing.com Canada

Sep 30, 2024
pulisher
Sep 30, 2024

aquestiveinvestordayreca.htm - SEC.gov

Sep 30, 2024
pulisher
Sep 30, 2024

Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate - AOL

Sep 30, 2024
pulisher
Sep 30, 2024

Trading Day Review: Aquestive Therapeutics Inc (AQST) Loses Momentum, Closing at 4.72 - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

AQST’s Stock Tango: The Dance of Gains and Losses in 2023 - The InvestChronicle

Sep 30, 2024
pulisher
Sep 30, 2024

Aquestive Therapeutics (NASDAQ:AQST) Earns "Market Outperform" Rating from JMP Securities - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

Aquestive Therapeutics (NASDAQ:AQST) Price Target Raised to $10.00 - MarketBeat

Sep 30, 2024
pulisher
Sep 28, 2024

146,155 Shares in Aquestive Therapeutics, Inc. (NASDAQ:AQST) Purchased by Deerfield Management Company L.P. Series C - MarketBeat

Sep 28, 2024
pulisher
Sep 28, 2024

Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day - GlobeNewswire

Sep 28, 2024
pulisher
Sep 28, 2024

Aquestive advances epinephrine treatments, completes study By Investing.com - Investing.com South Africa

Sep 28, 2024

Aquestive Therapeutics Inc Azioni (AQST) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Aquestive Therapeutics Inc Azioni (AQST) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Schobel Alexander Mark
Chief Innovation/Tech Officer
Mar 08 '24
Sale
5.19
25,000
129,685
1,040,371
$12.67
price up icon 0.88%
$114.96
price down icon 0.42%
$89.24
price up icon 3.56%
$58.48
price down icon 0.36%
$121.53
price up icon 0.83%
$11.61
price up icon 1.40%
Capitalizzazione:     |  Volume (24 ore):